Skip to main content
Equibles
ACHC logo

ACHC · Acadia Healthcare Company, Inc. · Metrics

Track ACHC — free

Use ACHC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ACHC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$31.51 -0.37 (-1.16%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.94B
Shares
92.21M
Volume · Oct 23 1.48M Avg daily vol (3M) 1.8M

ACHC metrics

88 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$31.51
Market cap
$2.94B

Price action

20 metrics
Price change (1W)
+2.7%
Price change (30D)
+8.5%
Price change (3M)
-6.3%
Price change (6M)
+16.6%
Price change (YTD)
+124.7%
Price change (1Y)
+35.9%
Trailing year
Price change (5Y)
-44.8%
52-week high
$35.61
52-week low
$11.68
Change from 52-week high
-10.5%
Change from 52-week low
+172.9%
Annualized volatility
64.7%
Annualized volatility (3M)
56.0%
Beta
1.0
RSI (14D)
63.4
Price vs SMA 50
+10.3%
Price vs SMA 200
+26.1%
Avg volume (3M)
1.81M
Relative volume
0.7
Average dollar volume
$53.42M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
92.21M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.5×
reciprocal yield 65.5%
EV / EBITDA
9.1×
reciprocal yield 11.0%
EV / EBIT
10.2×
reciprocal yield 9.8%
P / sales
0.9×
reciprocal yield 116.2%
P / book
1.5
reciprocal yield 68.3%
FCF yield
-4.6%
TTM · current market cap
Buyback yield
1.7%
P / FCF
—
P / operating cash flow
13.8
reciprocal yield 7.3%
Earnings yield
-38.9%

Historical valuation

8 metrics
P / E historical average (3Y)
18.9×
reciprocal yield 5.3%
P / E historical average (5Y)
21.6×
reciprocal yield 4.6%
EV / revenue historical average (3Y)
2.0×
reciprocal yield 48.8%
EV / revenue historical average (5Y)
2.5×
reciprocal yield 40.5%
EV / EBIT historical average (3Y)
10.4×
reciprocal yield 9.6%
EV / EBIT historical average (5Y)
10.4×
reciprocal yield 9.6%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.7%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
-33.4%
Gross profit (TTM)
—
Operating profit (TTM)
$582.73M
Net income (TTM)
−$1.13B
Trailing 12 months
Diluted EPS (TTM)
$-12.41
FCF margin
-4.0%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$37.15
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$6.63
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-12.55
Operating cash flow per diluted share (TTM)
$2.30
Free cash flow per diluted share (TTM)
$-1.51
Capital expenditures per diluted share (TTM)
$3.81
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.34
Book value per share
$21.78

Growth

11 metrics
Revenue growth YoY
-0.4%
Year over year
Net income growth YoY
-63.7%
Revenue (TTM)
$3.37B
Trailing 12 months
EPS growth YoY
-63.6%
Shares change YoY
+1.0%
Year over year · more shares
Revenue CAGR (3Y)
+8.3%
Revenue CAGR (5Y)
+9.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-56.9%
Return on assets
-20.3%
Debt / equity
1.2
Current ratio
1.6
EBITDA (TTM)
$652.91M
Free cash flow (TTM)
−$134.03M
Quick ratio
1.6
Interest coverage
—
Net debt / EBITDA
4.7
Return on invested capital
—
Trailing 12 months
Net cash
−$2.24B
Latest balance sheet
Cash & equivalents
$171.29M
Total assets
$5.55B
Total debt
$2.41B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$210.51M
Capital expenditures (TTM)
$344.55M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$30.99M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
318
13F filer change QoQ
+17
Institutional ownership
147.3%
Conviction holders (share of 13F filers)
2.2%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-3.3%
Holder tenure
12.9
Price vs estimated holder cost
+32.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
28.1%

Short interest

3 metrics
Short interest
24.7%
Latest settlement · 13.9 days to cover
Days to cover
13.9d
Short-squeeze score
78 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1520697 CUSIP 00404A109 13F (30d) 39 filings 39 filers Visit website Investor relations